Expert Face Lift Surgery at MyMedicPlus - Rejuvenate Your Look — Cost, Top Hospitals & Success Rates | MyMedicPlus

The composite facelift is an advanced rhytidectomy technique that elevates the lower eyelid, cheek, and lower face as a single unified anatomical unit — a composite flap — rather than operating on each layer separately. Introduced by surgeon Sam Hamra in the early 1990s as an evolution of his deep plane facelift, the composite lift incorporates the orbicularis oculi muscle (the muscle encircling the eye) into the elevated deep plane flap along with the overlying cheek fat and SMAS layer. This inclusion of the orbicularis muscle is the defining feature distinguishing the composite lift from standard deep plane techniques.

By mobilising the entire midface as a single composite unit including the orbicularis, the composite facelift achieves superior correction of periorbital ageing — including lower eyelid hollowing (tear trough deformity), malar mound prominence, and cheek descent — alongside the standard lower facial and neck improvements of a conventional facelift. The orbicularis muscle repositioned with the rest of the cheek tissue re-creates the youthful rounded cheek fullness characteristic of a patient's younger appearance, rather than producing the flat cheek typical of skin-only or SMAS-only techniques.

The procedure takes 4–6 hours under general anaesthesia and is performed in a hospital setting with one to two nights of inpatient stay. It requires a plastic surgeon with specific advanced facelift training and extensive experience with composite technique, as the dissection adjacent to the orbicularis muscle and facial nerve carries higher technical demands than standard facelift approaches.

The composite facelift is specifically indicated for patients with combined lower facial ageing and significant periorbital ageing — the two zones are anatomically linked, and standard facelift techniques that do not address the orbicularis and lower eyelid-cheek junction leave a visible boundary of remaining ageing between the rejuvenated midface and the untreated eyelid region. Primary indications include midface descent with prominent nasolabial folds and loss of cheek projection, lower eyelid hollowing (tear trough deformity) and festoons (malar bags), jowling with loss of mandibular border definition, and platysmal laxity of the neck.

Patients who previously underwent standard SMAS facelifts and achieved good lower facial improvement but retain significant periorbital ageing signs are ideal candidates for composite revision facelift. The technique is particularly suited to patients in their 50s and early 60s with moderate to significant midface and periorbital ageing who desire comprehensive rejuvenation through a single surgery rather than a facelift combined with a separate lower blepharoplasty.

Ideal candidates are adults aged 48–65 with moderate to significant midface descent, periorbital ageing including lower eyelid-cheek junction deformity, and lower facial jowling — whose anatomy and degree of ageing warrant a composite rather than standard SMAS approach. They must be non-smokers (or have abstained for 6 weeks minimum) given the extensive subperiosteal and sub-orbicularis dissection involved, have good general medical health sufficient for 4–6 hours of general anaesthesia, and have realistic expectations about surgical outcome and recovery timeline.

Contraindications specific to the composite approach include prior lower blepharoplasty with skin excision (which may compromise lower eyelid support and increase ectropion risk when the orbicularis is elevated), significant dry eye disease, prior retrobulbar haemorrhage, and patients who are not psychologically prepared for the longer recovery compared to standard facelift. The procedure is not appropriate for patients seeking minimal downtime or minor improvement — standard SMAS or mini-lift techniques are more proportionate for those patients.

The composite facelift represents the most extensive level of facelift surgery within a spectrum of techniques. At the less invasive end, mini-lift or MACS lift procedures address early jowling through shorter incisions and suture-based suspension. The standard SMAS facelift addresses the lower third of the face and neck by lifting and repositioning the SMAS beneath the skin. The deep plane facelift extends dissection beneath the SMAS into the deep plane to release retaining ligaments of the midface for superior cheek elevation. The composite facelift goes one step further by including the orbicularis oculi in the composite flap.

Sub-periosteal midface lift is an alternative approach to midface rejuvenation via an endoscopic or open approach that elevates the entire midface overlying the cheekbone — addressing similar anatomical zones as the composite but through a different surgical plane. Many surgeons combine elements of these techniques based on individual patient anatomy, tailoring the approach to achieve the optimal result for that specific face.

The composite facelift is typically combined with ancillary procedures including fat grafting to restore facial volume, neck liposuction and platysmal tightening, and periorbital rejuvenation (blepharoplasty or brow lifting). Surgeons experienced in composite lifting techniques must have advanced training in facial anatomy, particularly the facial nerve branches embedded within the SMAS, to operate safely within this deeper anatomical plane. Recovery from composite facelift is longer — typically 3–4 weeks before social reintegration — than from SMAS-only techniques, reflecting the more extensive tissue dissection.

The primary advantage of the composite facelift over standard techniques is its superior capacity to address the eyelid-cheek junction and lower eyelid region simultaneously with lower facial rejuvenation, avoiding the visible delineation between a rejuvenated cheek and an ageing lower eyelid that can appear in patients who undergo standard facelift without periorbital treatment. Long-term follow-up studies by Hamra and others demonstrate that composite facelift results maintain superior midface projection and periorbital improvement compared to deep plane techniques at 5–10 year follow-up.

Patients typically experience a more natural, rested appearance rather than a 'operated-on' look, because the lift repositions tissues in their original anatomical direction of ageing — superiorly — rather than the backward pull of skin-only techniques. The cheek roundness, lower eyelid support, and unified facial movement achievable with composite facelift are widely regarded among expert plastic surgeons as the most natural and comprehensive results available from a single facial rejuvenation procedure.

The composite facelift carries higher technical risk than standard facelift techniques because of the proximity of dissection to the lower eyelid, orbicularis muscle, and facial nerve branches. Lower eyelid ectropion — outward turning of the lower eyelid — is the most feared specific complication, occurring in approximately 1–3% of cases, typically temporary and managed with massage, eye drops, and occasionally minor revision surgery. Chemosis (conjunctival oedema) is common in the early post-operative period and resolves with conservative treatment.

Haematoma risk (2–5%), infection (0.5–1%), skin flap necrosis (particularly in smokers), nerve injury, and scar complications are shared with standard facelift techniques but may be slightly elevated due to the longer operative time and more extensive dissection. Due to the inclusion of the orbicularis in the flap, there is a specific small risk of temporary weakness of lower eyelid closure, requiring lubrication eye drops and eye protection until muscle function normalises. The composite approach should only be performed by surgeons with specific training and high case volume in this advanced technique.

Recovery from composite facelift is longer than from standard SMAS facelift due to the greater extent of dissection and the periorbital component of the surgery. Lower eyelid and cheek swelling is prominent for the first 2–3 weeks, and chemosis (eyelid swelling) can persist for 4–6 weeks. Patients typically remain at the surgical facility or local accommodation for 5–7 days before discharge, with suture removal at 7–10 days.

Most patients return to non-physical social activities at 3–4 weeks and to full work at 4–6 weeks. Strenuous exercise and UV exposure should be avoided for 6 weeks. Lubricating eye drops are prescribed for the first 2–4 weeks. Follow-up appointments at 1 week, 3 weeks, 6 weeks, 3 months, and 12 months assess wound healing, eyelid position, symmetry, and final aesthetic outcome. Lower eyelid position is critically assessed at each visit during the first 3 months.

The composite facelift is among the highest-priced facial cosmetic surgeries due to its technical complexity, longer operative time (4–6 hours), requirement for an advanced-trained surgeon, and 1–2 nights of hospital stay. In the United States, composite facelift costs USD 18,000–40,000 at leading plastic surgery centres. In the United Kingdom, GBP 15,000–30,000 under private care.

For international patients, experienced plastic surgeons trained in composite and deep plane techniques are available in India (Mumbai, Delhi), Thailand (Bangkok), and Turkey (Istanbul) at accredited private hospitals. Costs at these destinations range from USD 5,000–12,000 — representing savings of 60–75% compared to US prices. Patients should specifically verify the surgeon's composite facelift case volume and request to see before-and-after photograph portfolios demonstrating periorbital and midface outcomes. Medical travel packages including surgery, hospital stay, and post-operative care are available through MyMedicPlus partner hospitals.

For patients who want comprehensive midface and periorbital rejuvenation but are not suitable for or do not want the composite approach, alternatives include a deep plane facelift combined with a separate lower blepharoplasty (transconjunctival or with fat repositioning) performed either simultaneously or as staged procedures. This two-technique approach addresses the same anatomical zones as the composite but through separate surgical planes.

Non-surgical alternatives for lower eyelid-cheek rejuvenation include hyaluronic acid filler placement at the tear trough and lid-cheek junction, which addresses hollowing without surgery at a fraction of the cost, lasting 12–18 months. HIFU and radiofrequency microneedling provide modest non-surgical midface lifting. For patients with more limited facial ageing, standard SMAS facelift combined with lower blepharoplasty appropriately addresses their concerns without the recovery demands of the composite technique.